Linden Advisors’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-284,475
Closed -$2.91M 508
2022
Q4
$2.91M Hold
284,475
0.03% 266
2022
Q3
$2.84M Hold
284,475
0.03% 310
2022
Q2
$2.81M Sell
284,475
-680,000
-71% -$6.71M 0.03% 327
2022
Q1
$9.49M Hold
964,475
0.06% 220
2021
Q4
$9.45M Buy
+964,475
New +$9.42M 0.06% 197

Other funds holding PEPL

Linden Advisors's PEPL Position: Q1 2023 in Review

Linden Advisors sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 284,475 shares — an estimated $2.91M sold.

Linden Advisors first reported a position in PEPL in Q4 2021 and held it in 5 quarters. The position peaked at $9.49M in Q1 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

  • Linden Advisors reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • Linden Advisors sold 284,475 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $2.91M.
  • Linden Advisors first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
  • Linden Advisors's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $9.49M in Q1 2022.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on Linden Advisors's 13F filing for Q1 2023, filed 15 May 2023.